Sign In
Buy BGNE
$184.71
+0 (+0%)
At Close: Mar 28, 2025
CROs, clinical researchers brace for impact of coronavirus shutdown across China
09:40am, Thursday, 13'th Feb 2020
In recent years China has become a key region for clinical trial research sites, but the ongoing quarantine and partial travel lockdown to and from the country is putting a strain on research.
Is Amgen a Stock to Buy?
12:00pm, Saturday, 08'th Feb 2020
Amgen’s pipeline and an oncology collaboration in China are reasons to believe the recent revenue slowdown may be transient.
3 Canadian Biotechs to Consider Buying Today
12:00pm, Friday, 07'th Feb 2020
These developers of drugs for cancer, neurological conditions, and rare diseases may boost risk-taking investors' portfolios.
Analysts' Downgrades for January, 28th (ABBV, ACHC, ALGN, AMAT, ARGKF, ARWR, ATRC, ATVI, BGNE, BPFH)
08:26am, Tuesday, 28'th Jan 2020
Analysts’ downgrades for Tuesday, January 28th: AbbVie (NYSE:ABBV) was downgraded by analysts at ValuEngine from a hold rating to a sell rating. Acadia Healthcare (NASDAQ:ACHC) was downgraded by ana
111 Unveils New Video on The Impact of Chinese Policies to Medical Industry
10:00am, Sunday, 19'th Jan 2020
111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced the release of the sixth episode in its 111 Insight series. The title announced
111 Unveils New Video on the Impact of the Internet and other New Technologies on the Medical Industry
01:00pm, Friday, 17'th Jan 2020
111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced the release of the fifth episode in its 111 Insight series. The title announced
Principia Biopharma - The Future Worsens
05:00pm, Monday, 13'th Jan 2020
Phase 2 pemphigus additional data confirmed our previous concerns. ITP indication for PRN1008 remains vague. PRN2246/SAR442168 data is likely to disappoint inve
